BRIEF-Atossa Genetics Receives Positive Interim Review From Independent Safety Committee In Phase 1 Topical Endoxifen Dose Escalation Study In Men
April 24 (Reuters) - Atossa Genetics Inc:
* ATOSSA GENETICS RECEIVES POSITIVE INTERIM REVIEW FROM INDEPENDENT SAFETY COMMITTEE IN PHASE 1 TOPICAL ENDOXIFEN DOSE ESCALATION STUDY IN MEN
* ATOSSA GENETICS - INDEPENDENT SAFETY COMMITTEE REVIEWED BLINDED DATA FROM FIRST GROUP IN STUDY, CONCLUDED STUDY MAY ADVANCE TO NEXT DOSING LEVEL Source text for Eikon: Further company coverage: